This part of our website is currently under development. Please check back with us later. Thanks for your patience and interest.
Pfizer’s Rare Disease Drug to Be Approved Soon
18 January 2019
Environmentally-Friendly Methods in Pharma Industry
As Brexit nears, EMA improves staff retention forecast, commits to uninterrupted drug evaluations
17 January 2019
FDA planning new guidance, hires in cell and gene therapies for 2019